Key Ratios
Price & Volume
| Recent Price | $10.82 |
|---|---|
| 52 Week High | $30.99 |
| 52 Week Low | $0.88 |
| Average Volume (30 days) | 2.58M |
| Beta | (1.70) |
Dividend Information
| Yield % | -- |
|---|---|
| Annual Dividend | -- |
| Payout Ratio | -277.8% |
Financial Strength
| Quick Ratio (MRQ) | 20.9 |
|---|---|
| Current Ratio (MRQ) | 28.6 |
| LT Debt/Capital (MRQ) | -- |
| Total Debt/Equity (MRQ) | -- |
Valuation Ratios
| Price/Earnings (TTM) | 12.30 |
|---|---|
| Price/Sales (TTM) | 6.53 |
| Price/Book (MRQ) | 5.92 |
| Price/Cash Flow (TTM) | 41.70 |
Management Effectiveness
| Return on Equity (TTM) | 99.6% |
|---|---|
| Return on Assets (TTM) | 95.6% |
| Return on Investment (TTM) | 99.4% |
Profitability
| Gross Margin (TTM) | 74.1% |
|---|---|
| EBIT Margin (TTM) | 52.7% |
| Profit Margin (TTM) | 58.8% |
Co-Diagnostics is a molecular diagnostics company with a unique mathematical approach to DNA test design. Our products offer a unique value proposition, making the detection of infectious disease and genetic disorders far more affordable worldwide.
Co-Diagnostics, Inc.
2401 South Foothill Dr, Suite D
Salt Lake City, Utah 84109
United States
1 (801) 438-1036
© 2016-2020 Co-Diagnostics, Inc. • All Rights Reserved.
COMPANY
LATEST NEWS RELEASE
Co-Diagnostics, Inc. Issues Operational Update
Salt Lake City, Utah – September 1, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX) (the Company), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, issued the following statement concerning the progress of the...
read more
Co-Diagnostics is a molecular diagnostics company with a unique mathematical approach to DNA test design. Our products offer a unique value proposition, making the detection of infectious disease and genetic disorders far more affordable worldwide.
Co-Diagnostics, Inc.
2401 South Foothill Dr, Suite D
Salt Lake City, Utah 84109
United States
1 (801) 438-1036
COMPANY
© 2016-2020 Co-Diagnostics, Inc. • All Rights Reserved.